Presentation TVT 2022 POINT: The Interaction Between Echo Hemodynamics and Structural Aortic Valve Deterioration Presenter: Michael J. Reardon June 09, 2022
Presentation TVT 2022 Acurate Neo2: Update From the ACURATE IDE and Related Studies Presenter: Michael J. Reardon June 08, 2022
Presentation TVT 2022 Avoiding PVL by Valve design in the Younger Patients Presenter: Michael Reardon June 08, 2022
Presentation TVT 2022 Hemodynamics and the Impact For Younger Patients Presenter: Michael Reardon June 08, 2022
Presentation TVT 2022 Evidence of Structural Valve Deterioration After TAVI: Recent Echo Findings Presenter: Michael J. Reardon June 08, 2022
News Conference News TVT 2019 Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR Michael O'Riordan June 19, 2019
News Conference News TVT 2019 Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry Shelley Wood June 17, 2019
News Conference News TVT 2017 Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial Shelley Wood June 16, 2017